Response Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing therapies for weight management and metabolic health in high-need populations, today announced that data from its ...
Triglycerides rarely make headlines the way cholesterol does, yet they quietly shape heart health in equally powerful ways. When levels climb, the body is often responding to a familiar pattern—too ...
Triglycerides are the most common type of fat in the blood, and they play an essential role in providing the body with energy. After we eat, any calories our body does not immediately use are ...
Triglycerides are a type of fat found in your blood. When you eat, your body turns calories into triglycerides and stores them for energy. They are necessary for energy. When their levels get too high ...
BOULDER, Colo., March 18, 2026 /PRNewswire/ -- The National Triglyceride Alliance (NTA) proudly marks its one-year anniversary this month, coinciding with National Triglycerides Day on March 28, a ...
The higher a person’s triglyceride levels, the more likely they are to experience acute pancreatitis. Very high triglycerides occur when triglyceride levels reach 500 milligrams per deciliter (mg/dl), ...
The Miami Heat star scored the second-most points in a game in NBA history on Tuesday night. Some may question exactly how he got there Second in points, last in ethics? That will be the accusation ...
What Is Redemplo, and Why Does It Matter? Redemplo (plozasiran) is a type of medicine called a small interfering RNA (siRNA) therapy approved to help lower extremely high triglyceride levels in adults ...
The FDA approved plozasiran (Redemplo) for the reduction of triglycerides in people with familial chylomicronemia syndrome (FCS), the agency announced. The small interfering RNA (siRNA) therapy, ...
Plozasiran is the first FDA-approved drug for familial chylomicronemia syndrome, reducing triglycerides as an adjunct to diet. The phase 3 PALISADE trial showed significant triglyceride reduction with ...
NEW ORLEANS — When added to standard lipid-lowering therapy, olezarsen, a drug approved in 2024 for patients with familial chylomicronemia syndrome, significantly lowered triglycerides and reduced the ...
CHICAGO, Nov 8 (Reuters) - A single infusion of CRISPR Therapeutics' (CRSP.BN), opens new tab experimental gene therapy was safe and reduced levels of harmful LDL cholesterol and triglycerides by half ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results